Vasomotor Symptoms of Menopause – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033 thelansis.com

Vasomotor symptoms (VMS), which include hot flashes and night sweats, are commonly considered the primary indications of menopause. These symptoms involve intense heat accompanied by sweating and reddening of the skin, primarily felt around the head, neck, chest, and upper back. The majority of women undergoing the menopausal transition experience VMS. The exact mechanisms behind hot flashes are not fully comprehended. However, they likely result from the complex interplay of various physiological systems in the body’s central and peripheral regions. Reproductive hormones are likely to play a crucial role in this process. The age of menopausal onset varies significantly, typically falling between 40 to 55 years of age. In the United States, the average age of onset is approximately 51 years, although female smokers experience this transition about two years earlier. Several key factors increase the risk of experiencing VMS, including lower education levels, smoking, obesity, and negative emotional states.
• Vasomotor symptoms are observed in around 80% of women in the US during the menopausal transition, but their frequency varies daily. On average, women report having 4 to 5 hot flashes daily, although some women may experience as many as 20 daily occurrences.

Thelansis’s “Vasomotor Symptoms of Menopause Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Vasomotor Symptoms of Menopause treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Vasomotor Symptoms of Menopause across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Vasomotor Symptoms of Menopause Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Vasomotor Symptoms of Menopause – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033